PLSE
Pulse Biosciences Inc
51.60$
-0.4%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -389.4% | – | – | – | -549.5% | -1,625.1% | – | -15,161.6% | -5,589.0% | -3,639.7% | -4,310.8% | -5,155.9% | |
| – | 17.5% | – | – | – | 17.2% | 34.0% | – | 297.7% | 98.1% | 63.6% | 58.5% | 86.4% | |
| – | 192.2% | – | – | – | 408.2% | 682.8% | – | 6,531.4% | 1,882.6% | 476.8% | 1,145.9% | 1,474.4% | |
| – | 85.6% | – | – | – | 189.6% | -323.3% | – | 211.6% | -1,082.2% | 291.3% | 90.3% | -94.1% | |
| – | 2.5% | – | – | – | 3.2% | 5.4% | – | 72.1% | 39.8% | 8.2% | 20.7% | 24.5% | |
| – | -2.5% | – | – | – | -3.2% | -5.4% | – | -72.1% | -39.8% | -8.2% | -20.7% | -24.5% | |
| – | 6.0% | – | – | – | – | 42.3% | – | 689.5% | 222.0% | – | – | – | |
| – | 46.2% | – | – | – | 2,896.8% | 1,779.7% | – | 2,286.0% | 144.3% | 551.6% | 12,004.6% | 4,781.4% | |
| – | -346.0% | – | – | – | 2,344.1% | 149.2% | – | -12,947.7% | -5,484.5% | -3,096.3% | 7,673.0% | -399.1% | |
| – | -391.9% | – | – | – | -552.7% | -1,630.5% | – | -15,233.7% | -5,628.8% | -3,647.9% | -4,331.6% | -5,180.4% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.